These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16365146)

  • 1. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance.
    Terabe M; Swann J; Ambrosino E; Sinha P; Takaku S; Hayakawa Y; Godfrey DI; Ostrand-Rosenberg S; Smyth MJ; Berzofsky JA
    J Exp Med; 2005 Dec; 202(12):1627-33. PubMed ID: 16365146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis.
    Terabe M; Berzofsky JA
    Trends Immunol; 2007 Nov; 28(11):491-6. PubMed ID: 17964217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta.
    Terabe M; Khanna C; Bose S; Melchionda F; Mendoza A; Mackall CL; Helman LJ; Berzofsky JA
    Cancer Res; 2006 Apr; 66(7):3869-75. PubMed ID: 16585215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.
    Ragin MJ; Sahu N; August A
    Infect Immun; 2006 Jan; 74(1):282-8. PubMed ID: 16368982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver.
    Miyagi T; Takehara T; Tatsumi T; Kanto T; Suzuki T; Jinushi M; Sugimoto Y; Sasaki Y; Hori M; Hayashi N
    Int J Cancer; 2003 Aug; 106(1):81-9. PubMed ID: 12794761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis.
    Ambrosino E; Terabe M; Halder RC; Peng J; Takaku S; Miyake S; Yamamura T; Kumar V; Berzofsky JA
    J Immunol; 2007 Oct; 179(8):5126-36. PubMed ID: 17911598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
    J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Lang GA; Exley MA; Lang ML
    Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity.
    Faunce DE; Palmer JL; Paskowicz KK; Witte PL; Kovacs EJ
    J Immunol; 2005 Sep; 175(5):3102-9. PubMed ID: 16116199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
    Jiang S; Game DS; Davies D; Lombardi G; Lechler RI
    Eur J Immunol; 2005 Apr; 35(4):1193-200. PubMed ID: 15770696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1-restricted T cells and tumor immunity.
    Swann JB; Coquet JM; Smyth MJ; Godfrey DI
    Curr Top Microbiol Immunol; 2007; 314():293-323. PubMed ID: 17593666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells.
    Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE
    J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
    Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
    J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model.
    Kim JO; Kim DH; Chang WS; Hong C; Park SH; Kim S; Kang CY
    J Allergy Clin Immunol; 2004 Dec; 114(6):1332-8. PubMed ID: 15577831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.